1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular CarcinomaAdvanced Hepatocellular CarcinomaRecruitingPhase 1 / Phase 22025-07-04NCT05797805